Allurion Technologies (ALUR) Competitors $0.45 +0.04 (+9.69%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ALUR vs. GUTS, FONR, EDAP, LNSR, VANI, MODD, MGRM, NSPR, ECOR, and HYPRShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Fractyl Health (GUTS), FONAR (FONR), Edap Tms (EDAP), LENSAR (LNSR), Vivani Medical (VANI), Modular Medical (MODD), Monogram Orthopaedics (MGRM), InspireMD (NSPR), electroCore (ECOR), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Fractyl Health FONAR Edap Tms LENSAR Vivani Medical Modular Medical Monogram Orthopaedics InspireMD electroCore Hyperfine Fractyl Health (NASDAQ:GUTS) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking. Does the MarketBeat Community favor GUTS or ALUR? Allurion Technologies received 4 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 87.50% of users gave Allurion Technologies an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes3100.00% Underperform VotesNo VotesAllurion TechnologiesOutperform Votes787.50% Underperform Votes112.50% Do institutionals & insiders hold more shares of GUTS or ALUR? 21.4% of Allurion Technologies shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is GUTS or ALUR more profitable? Allurion Technologies has a net margin of -71.24% compared to Fractyl Health's net margin of -64,849.48%. Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% Allurion Technologies -71.24%N/A -56.75% Which has better valuation and earnings, GUTS or ALUR? Fractyl Health has higher earnings, but lower revenue than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$120K825.72-$77.09M-$12.19-0.17Allurion Technologies$53.47M0.55-$80.61M-$0.48-0.94 Does the media favor GUTS or ALUR? In the previous week, Allurion Technologies had 6 more articles in the media than Fractyl Health. MarketBeat recorded 13 mentions for Allurion Technologies and 7 mentions for Fractyl Health. Allurion Technologies' average media sentiment score of 0.36 beat Fractyl Health's score of 0.16 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fractyl Health 1 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Allurion Technologies 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate GUTS or ALUR? Fractyl Health presently has a consensus price target of $22.00, indicating a potential upside of 967.96%. Allurion Technologies has a consensus price target of $2.88, indicating a potential upside of 534.94%. Given Fractyl Health's higher possible upside, research analysts plainly believe Fractyl Health is more favorable than Allurion Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryAllurion Technologies beats Fractyl Health on 10 of the 15 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$26.37M$4.47B$5.06B$19.87BDividend YieldN/A36.79%4.97%3.50%P/E Ratio-0.9412.8689.0235.66Price / Sales0.5545.351,207.2817.95Price / CashN/A52.2339.1717.98Price / Book-0.455.676.084.59Net Income-$80.61M$13.76M$119.07M$985.93M7 Day Performance15.39%-1.08%-1.84%0.45%1 Month Performance-35.69%0.58%-3.65%1.05%1 Year Performance-87.63%50.91%31.62%24.67% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.3247 of 5 stars$0.45+9.7%$2.88+534.9%-88.1%$26.37M$53.47M-0.94501Analyst RevisionGap UpHigh Trading VolumeGUTSFractyl Health1.6229 of 5 stars$2.06-5.9%$22.00+968.0%N/A$105.34M$120,000.000.00102FONRFONAR1.9578 of 5 stars$14.89+0.9%N/A-18.3%$93.41M$102.88M10.64480EDAPEdap Tms2.4619 of 5 stars$2.45+2.5%$19.00+675.5%-45.7%$88.68M$65.42M0.00307Analyst DowngradeLNSRLENSAR2.1504 of 5 stars$7.28-2.5%$8.00+9.9%+237.0%$86.76M$42.16M0.00110Positive NewsVANIVivani Medical3.1093 of 5 stars$1.29flat$3.00+132.6%+35.6%$76.41MN/A0.0020MODDModular Medical3.0504 of 5 stars$2.06-1.9%$5.00+142.7%+104.0%$72.60MN/A0.0039Positive NewsMGRMMonogram Orthopaedics1.094 of 5 stars$2.00-2.0%N/A-38.8%$70M$370,000.000.0028NSPRInspireMD2.5564 of 5 stars$2.67+3.9%$4.50+68.5%-4.0%$67.04M$6.20M0.0050Analyst ForecastECORelectroCore0.8003 of 5 stars$9.94-1.5%N/A+62.7%$66.14M$16.03M0.0050Analyst RevisionHYPRHyperfine2.7519 of 5 stars$0.90+3.4%$1.43+58.3%-23.1%$63.15M$11.03M0.00190High Trading Volume Related Companies and Tools Related Companies Fractyl Health Competitors FONAR Competitors Edap Tms Competitors LENSAR Competitors Vivani Medical Competitors Modular Medical Competitors Monogram Orthopaedics Competitors InspireMD Competitors electroCore Competitors Hyperfine Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ALUR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALUR Stock Alerts